Related Experiment Video

Updated: Apr 24, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K

Additional compensatory mechanisms altering antisense oligonucleotide suppression of BCL2: effects upon AKT1 and

Marvin Rubenstein1, Courtney M P Hollowell2, Patrick Guinan3

  • 1Division of Cellular Biology, Hektoen Institute for Medical Research, Chicago, IL, U.S.A. Division of Urology, Stroger Hospital of Cook County, Chicago, IL, U.S.A. Department of Biochemistry, Rush University Medical Center, Chicago, IL, U.S.A. Department of Urology, Rush University Medical Center, Chicago, IL, U.S.A. DrMarv@Prodigy.net.

In Vivo (Athens, Greece)
|September 6, 2014
PubMed

Insights

Antisense oligonucleotides targeting B-cell lymphoma-2 (BCL-2) in prostate cancer cells triggered compensatory gene expression, including androgen receptor and AKT1, suggesting potential therapeutic resistance.

Area of Science:

  • Molecular Oncology
  • Cancer Therapeutics
  • Gene Regulation

Background:

  • Antisense oligonucleotides (ASOs) are investigated for targeting regulatory proteins in prostate cancer.
  • B-cell lymphoma-2 (BCL-2) is an apoptosis-inhibitory protein frequently dysregulated in cancer.

Purpose of the Study:

  • To evaluate the effects of mono- and bispecific ASOs targeting BCL-2 in LNCaP prostate cancer cells.
  • To investigate cellular compensatory mechanisms in response to BCL-2 suppression.
  • To assess the expression of key genes related to apoptosis, androgen sensitivity, and tumor progression.

Main Methods:

  • LNCaP cells were treated with ASOs targeting BCL-2, delivered via a nanoparticle system with lipofectin.
  • Gene expression levels of BCL-2, caspase-3, androgen receptor, p300, IL-6, AKT1, and STAT3 were analyzed.

Main Results:

  • ASO treatment comparably suppressed BCL-2 expression in LNCaP cells.
  • Cells exhibited compensatory suppression of caspase-3 and enhanced expression of androgen receptor, p300, IL-6, AKT1, and STAT3.
  • These changes suggest increased androgen sensitivity and a gene activation pattern associated with advanced prostate tumors.

Conclusions:

  • BCL-2 suppression by ASOs in prostate cancer cells induces compensatory mechanisms.
  • These mechanisms involve enhanced androgen receptor signaling and activation of oncogenes like AKT1 and STAT3.
  • Findings indicate potential for therapeutic resistance and suggest further investigation into these compensatory pathways.
Keywords:
AntisenseBCL-2prostate cancertherapy

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

7.6K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K